LOXL2-induced PEAR1 Ser891 phosphorylation suppresses CD44 degradation and promotes triple-negative breast cancer metastasis
Article in Journal of Clinical Investigation (August 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Journal of Clinical Investigation (August 2024)
Article in Naunyn-Schmiedeberg's Archives of Pharmacology (July 2024)
Book chapter (May 2024)